
Relaxin H2 (human)
Product Number:
Price range: $324.50 through $2,299.00
Sequence:
Glp-Leu-Tyr-Ser-Ala-Leu-Ala-Asn-Lys-Cys-Cys-His-Val-Gly-Cys-Thr-Lys-Arg-Ser-Leu-Ala-Arg-Phe-Cys-OH-InterDimer-Asp-Ser-Trp-Met-Glu-Glu-Val-Ile-Lys-Leu-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Met-Ser-Thr-Trp-Ser-OH
(Chain A Cys10 and Cys15, Chain A Cys11 and Chain B Cys11; Chain A Cys24 and Chain B Cys23)
Description
Relaxin H2 (human) is a naturally occurring peptide hormone belonging to the relaxin family of insulin-like peptides. It plays a key role in various physiological processes, including reproductive health, tissue remodeling, cardiovascular regulation, and antifibrotic activity. The human Relaxin H2 form is the primary circulating isoform in humans and exhibits potent vasodilatory, anti-inflammatory, and antifibrotic properties.
The Relaxin H2 peptide is composed of two peptide chains (A-chain and B-chain), connected by disulfide bonds, resembling the structural framework of insulin. The B-chain is essential for receptor binding and activation, primarily interacting with Relaxin Family Peptide Receptor 1 (RXFP1).
SEQUENCE: Chain A: Glp-Leu-Tyr-Ser-Ala-Leu-Ala-Asn-Lys-Cys-Cys-His-Val-Gly-Cys-Thr-Lys-Arg-Ser-Leu-Ala-Arg-Phe-Cys-OH-InterDimer-Chain B: Asp-Ser-Trp-Met-Glu-Glu-Val-Ile-Lys-Leu-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Met-Ser-Thr-Trp-Ser-OH (Chain A Cys10 and Cys15, Chain A Cys11 and Chain B Cys11; Chain A Cys24 and Chain B Cys23)
ONE-LETTER SEQUENCE: Glp-LYSALANKCCHVGCTKRSLARFC-InterDimer-DSWMEEVIKLCGRELVRAQIAICGMSTWS (Chain A Cys10 and Cys15, Chain A Cys11 and Chain B Cys11; Chain A Cys24 and Chain B Cys23)
MOLECULAR FORMULA: C256H408N74O74S8
MOLECULAR WEIGHT: 5963.04
STORAGE CONDITIONS: -20 ± 5 °C
CAS REGISTRY NUMBER: [99489-94-8]
SYNONYMS: Human Relaxin-2, H2 Relaxin, RLN2, Relaxin Peptide Hormone, Insulin-like Peptide H2, Relaxin, Human, Prorelaxin, Relaxin-2 Precursor,Relaxin A/B Chain, Serelaxin
RESEARCH AREA: Cardiovascular, Reproductive, Anti-Inflammatory, Cancer
SKU(s): 966545A, 966545B, 966545C
KEYWORDS: Antifibrotic, Cardioprotective, Vasodilation, Tissue Remodeling, Reproductive Health
REFERENCES:
- Osheroff, P. L.; Chien, P.; Wetzel, D.; Walsh, D.; Finney, R. Relaxin and the regulation of collagen. Proc. Natl. Acad. Sci. USA 1992, 89, 2384–2389.
- Arrese, E. L.; Wells, M. A. Lipid metabolism in insects. J. Lipid Res. 1997, 38, 68–74.
- Qin, X.; Kato, K.; Ochsner, R. A.; Berman, R.; McVicar, J. P.; Chacko, D.; Rohan, P.; Doughty, S. A. Biologic effects of relaxin on reproduction. Biol. Reprod. 1997, 56, 800–810.
- Shpakov, A.; Kolesnikova, T.; Vlasenko, L.; Arseniev, A. Relaxin in human reproduction. Ann. N. Y. Acad. Sci. 2005, 1041, 305–312.
- Samuel, C. S.; Hewitson, T. D.; Dean, R. C.; Johnson, S. H. Relaxin as a therapeutic agent for kidney fibrosis. Kidney Int. 2006, 69, 1498–1505.
- Moore, X.-l.; Li, Y.; Zhang, M.; Wang, X. Relaxin and its receptors in the human endocrine system. Endocrinology 2007, 148, 1582–1588.
- Kapila, S. Relaxin and its role in musculoskeletal and neuronal health. J. Musculoskelet. Neuronal Interact. 2003, 3, 401–406.
Additional information
| Research Area | |
|---|---|
| Salt Type | |
| Size |
